Apoptosis pathways in neuroblastoma therapy

Simone Fulda1, Klaus Michael Debatin

  • 1University Children's Hospital, Prittwitzstr. 43, D-89075 Ulm, Germany.

Cancer Letters
|July 26, 2003
PubMed

Insights

Apoptosis, or programmed cell death, is vital for tissue balance. Understanding how neuroblastoma cells resist apoptosis is key to developing new cancer therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Death Research

Background:

  • Apoptosis, the body's programmed cell death process, is essential for maintaining tissue homeostasis.
  • Dysregulation of apoptosis, leading to an imbalance between cell death and proliferation, is a hallmark of tumor formation.
  • Many cancer treatments, including chemotherapy and radiation, induce cancer cell death primarily through apoptosis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying apoptosis induction in cancer therapy.
  • To understand how neuroblastoma cells evade apoptosis, leading to therapeutic resistance.
  • To identify novel therapeutic strategies targeting apoptosis resistance in neuroblastoma.

Main Methods:

  • Review of current literature on apoptosis and cancer therapy.
  • Analysis of molecular pathways involved in apoptosis regulation.
  • Examination of resistance mechanisms in neuroblastoma cells.

Main Results:

  • Impaired apoptosis activation is a significant factor in neuroblastoma's resistance to anticancer treatments.
  • Understanding the molecular basis of apoptosis evasion is crucial for overcoming treatment failure.
  • Insights into apoptosis and alternative cell death pathways can guide the development of new therapeutic approaches.

Conclusions:

  • Targeting apoptosis resistance mechanisms in neuroblastoma offers a promising avenue for improving treatment efficacy.
  • Further research into the molecular intricacies of cell death pathways is essential for advancing neuroblastoma therapy.
  • Novel therapeutic strategies should focus on overcoming neuroblastoma's ability to evade programmed cell death.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...